Tagged with R

Asia Despite underdevelopment in many facets; Southeast Asia is actually at the forefront of a digital revolution in healthcare; with digital solutions helping bring about more efficient, cost-effective, and tailored patient care. “Cloud-based technology, mobile enablement and fees for service models will lead to faster deployment and increased benefits for patients.…

Switzerland Ensuring a fair allocation of rights and returns from collaboratively developed technologies is a continual challenge for university Tech Transfer Offices – swiTT president Stefan Kohler discusses the current challenges and shares his perspective on the role of university developed IP in the Swiss life science ecosystem. What are some…

Luxembourg Luxembourg is steadily increasing its social security coverage to include a broader percentage of its population. Luxembourg has one of the highest health expenditures per capita in the world; second only to the USA. A whopping 44.5% of those working in Luxembourg are non-nationals; a percentage way ahead of anywhere else…

Singapore Singapore’s location at the heart of the APAC region, expertise in logistics and cold chain management, and smart investment in infrastructure has helped make the Lion City an indisputable global heavyweight in pharma logistics. “From a logistics standpoint, Singapore serves as a pivotal gateway to the broader region—namely because of…

Switzerland Beat Berger (BB) and Dr Uwe Schmelzer (US) of Swiss API distributor DCS Pharma discuss growth segments in the global generics market, international hotspots, and the benefits of being based in Switzerland.   As an API distributor, what segments of the global generics market do you see the most growth…

Singapore Ong Wee Min, Executive Director of Sales, highlights why Marina Bay Sands is the venue of choice for many international and regional healthcare conferences, the importance of being a true partner in accommodating very diverse client needs, and how Marina Bay Sands has been able to significantly contribute to Singapore’s…

Taiwan Chih-Kung Lee, Minister of Economic Affairs of the Republic of China (Taiwan) provides insights into Taiwan’s “new economic model” recently established by the new government to boost the country’s economic growth and ensure Taiwan renews its role as an innovation pioneer. He also documents the crucial role that the pharmaceutical…

Switzerland Not all impactful innovation involves the development of new chemical or biological entities, and the value of such innovation must be recognized in pricing processes argues Gebro Pharma Switzerland CEO Marcel Plattner. We understand you serve as the head of the executive committee for market access and pricing within the…

Taiwan Kao Su-Chin Chang, founder and chairman of Weidar Chemical and Pharmaceutical, describes the robust development and international expansion of this historical domestic pharmaceutical manufacturer and the company’s enduring commitment to maintaining the excellence of its manufacturing capacity, which has allowed Weidar to establish itself as one of the foremost generics…

Ireland Barry Joyce, MD at VWR Ireland, takes us through the priorities of the first few months of his appointment, the strategic position of VWR in Ireland and within the global VWR (NASDAQ: VWR) organization, the importance of taking a partnership approach with clients instead of a transactional one, and his…

Ireland The strong flow of FDI into Ireland has led to a vibrant ecosystem of Irish service providers, who have grown up servicing the needs of pharma MNCs. Working for FDI clients has put Irish companies to the test and pushed them to work to the highest standards. “Top global pharma…

Switzerland Ulf Claesson provides a fascinating and passionate account of how his firm is aiming to remove ‘guesswork’ and estimations for medical practices whilst highlighting interesting developments in the global clinical research industry. To begin with, we understand that you are a bit of a spin-out & start-up artist, and have…